Similarly, the lncRNAs MIR210HG, LINC01503, CRNDE, HOXC-AS1 and MIR22HG were found to play an essential role as risk factors in prolonging the survival time of glioma patients also in high agreement with our findings. This evidence concerns the gene CRNDE and central nervous system cancer.